NASDAQ:TWST Twist Bioscience (TWST) Stock Forecast, Price & News $16.67 -0.31 (-1.83%) (As of 06/7/2023 ET) Add Compare Share Share Today's Range$16.53▼$17.6750-Day Range$11.49▼$16.9852-Week Range$11.46▼$58.76Volume1.33 million shsAverage Volume1.24 million shsMarket Capitalization$952.69 millionP/E RatioN/ADividend YieldN/APrice Target$26.17 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Twist Bioscience MarketRank™ ForecastAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside57.0% Upside$26.17 Price TargetShort InterestBearish24.20% of Shares Sold ShortDividend StrengthN/ASustainability-1.42Upright™ Environmental ScoreNews Sentiment0.66Based on 5 Articles This WeekInsider TradingAcquiring Shares$132,000 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($3.96) to ($3.14) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.23 out of 5 starsMedical Sector289th out of 981 stocksBiological Products, Except Diagnostic Industry43rd out of 159 stocks 3.3 Analyst's Opinion Consensus RatingTwist Bioscience has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 4 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $26.17, Twist Bioscience has a forecasted upside of 57.0% from its current price of $16.67.Amount of Analyst CoverageTwist Bioscience has only been the subject of 1 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted24.20% of the outstanding shares of Twist Bioscience have been sold short.Short Interest Ratio / Days to CoverTwist Bioscience has a short interest ratio ("days to cover") of 9.9.Change versus previous monthShort interest in Twist Bioscience has recently increased by 11.80%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldTwist Bioscience does not currently pay a dividend.Dividend GrowthTwist Bioscience does not have a long track record of dividend growth. Previous Next 4.4 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreTwist Bioscience has received a 65.93% net impact score from Upright. The largest positive contribution comes from its "Creating knowledge" impact, which is false driven by its "Deoxyribonucleic acid (DNA)" and "Monoclonal antibodies for research" products. See details.Environmental SustainabilityThe Environmental Impact score for Twist Bioscience is -1.42. Previous Next 3.1 News and Social Media Coverage News SentimentTwist Bioscience has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Twist Bioscience this week, compared to 3 articles on an average week.Search Interest29 people have searched for TWST on MarketBeat in the last 30 days. This is an increase of 12% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Twist Bioscience to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Twist Bioscience insiders have bought more of their company's stock than they have sold. Specifically, they have bought $132,000.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders11.80% of the stock of Twist Bioscience is held by insiders. A high percentage of insider ownership can be a sign of company health. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Twist Bioscience are expected to grow in the coming year, from ($3.96) to ($3.14) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Twist Bioscience is -4.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Twist Bioscience is -4.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTwist Bioscience has a P/B Ratio of 1.19. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Twist Bioscience (NASDAQ:TWST) StockTwist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. Its products include genes, oligo pools, Next Generation Sequencing (NGS), variant libraries, synthetic controls, antibody discovery, and SARS-CoV-2 Tools. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment consists of Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck on February 4, 2013 and is headquartered in San Francisco, CA.Read More Receive TWST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Twist Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address TWST Stock News HeadlinesJune 8, 2023 | americanbankingnews.comTwist Bioscience Co. (NASDAQ:TWST) Receives $26.17 Consensus PT from BrokeragesJune 1, 2023 | americanbankingnews.comTwist Bioscience (NASDAQ:TWST) Stock Price Up 6.2%June 8, 2023 | Legacy Research (Affiliate) (Ad)“You need at least $100 of this asset – and it’s NOT gold” – Dr. Nomi Prin$100 is all you need… Former Goldman Sachs managing director Dr. Nomi Prins has identified an investment she’s calling ‘the world’s hardest asset’ – and she’s recommending it to friends, family, and followers.May 31, 2023 | finanznachrichten.deTwist Bioscience Corporation: Twist Bioscience to Present at ITF World 2023May 26, 2023 | americanbankingnews.comTwist Bioscience (NASDAQ:TWST) Stock Price Down 8.6%May 24, 2023 | seekingalpha.comTwist Bioscience: Progress On Margins Could Put A Floor Under The StockMay 24, 2023 | americanbankingnews.comTwist Bioscience (NASDAQ:TWST) Trading Up 5.1%May 19, 2023 | seekingalpha.comReconsidering Twist BiosciencesJune 8, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.May 14, 2023 | americanbankingnews.comDennis Cho Purchases 10,000 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockMay 14, 2023 | americanbankingnews.comTwist Bioscience Co. (NASDAQ:TWST) Given Consensus Recommendation of "Moderate Buy" by BrokeragesMay 10, 2023 | americanbankingnews.comRobert W. Baird Trims Twist Bioscience (NASDAQ:TWST) Target Price to $18.00May 8, 2023 | msn.comBarclays Maintains Twist Bioscience (TWST) Overweight RecommendationMay 8, 2023 | markets.businessinsider.comAnalyst Ratings for Twist BioscienceMay 8, 2023 | americanbankingnews.comBarclays Lowers Twist Bioscience (NASDAQ:TWST) Price Target to $20.00May 7, 2023 | finance.yahoo.comTwist Bioscience Corporation (NASDAQ:TWST) Q2 2023 Earnings Call TranscriptMay 5, 2023 | bizjournals.comDespite record quarterly revenue, Twist Bioscience to cut 25% of workforceMay 5, 2023 | msn.comRecap: Twist Bioscience Q2 EarningsMay 5, 2023 | americanbankingnews.comReviewing Taysha Gene Therapies (NASDAQ:TSHA) and Twist Bioscience (NASDAQ:TWST)May 4, 2023 | benzinga.comEarnings Preview: Twist BioscienceMay 4, 2023 | americanbankingnews.comTwist Bioscience (NASDAQ:TWST) Reaches New 12-Month Low at $11.89May 3, 2023 | americanbankingnews.comTwist Bioscience (TWST) to Release Quarterly Earnings on FridayApril 25, 2023 | americanbankingnews.comTwist Bioscience Co. to Post Q2 2023 Earnings of ($1.04) Per Share, SVB Leerink Forecasts (NASDAQ:TWST)April 23, 2023 | americanbankingnews.comTwist Bioscience (NASDAQ:TWST) Price Target Cut to $20.00 by Analysts at The Goldman Sachs GroupApril 20, 2023 | finance.yahoo.comTwist Bioscience Enters into Third Collaboration with Astellas to Support Antibody Discovery for ImmunotherapiesApril 19, 2023 | americanbankingnews.comBrokerages Set Twist Bioscience Co. (NASDAQ:TWST) Price Target at $33.83April 18, 2023 | msn.comNVIDIA To Rally Over 31%? Here Are 10 Other Analyst Forecasts For TuesdaySee More Headlines TWST Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TWST Company Calendar Last Earnings5/05/2023Today6/08/2023Next Earnings (Estimated)8/04/2023Fiscal Year End9/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:TWST CUSIPN/A CIK1581280 Webwww.twistbioscience.com Phone(800) 719-0671FaxN/AEmployees652Year FoundedN/APrice Target and Rating Average Stock Price Forecast$26.17 High Stock Price Forecast$36.00 Low Stock Price Forecast$18.00 Forecasted Upside/Downside+57.0%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($3.77) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-217,860,000.00 Net Margins-93.32% Pretax Margin-92.92% Return on Equity-27.95% Return on Assets-23.08% Debt Debt-to-Equity RatioN/A Current Ratio6.79 Quick Ratio6.23 Sales & Book Value Annual Sales$203.57 million Price / Sales4.68 Cash FlowN/A Price / Cash FlowN/A Book Value$14.01 per share Price / Book1.19Miscellaneous Outstanding Shares57,150,000Free Float50,404,000Market Cap$952.69 million OptionableNot Optionable Beta1.16 Key ExecutivesEmily Marine LeproustChairman & Chief Executive OfficerPatrick J. FinnPresident & Chief Operating OfficerJames M. ThorburnChief Financial OfficerSiyuan ChenChief Technology OfficerNimisha SrivastavaSenior Vice President-Research & DevelopmentKey CompetitorsExscientiaNASDAQ:EXAIValnevaNASDAQ:VALNADMA BiologicsNASDAQ:ADMAScilexNASDAQ:SCLXREGENXBIONASDAQ:RGNXView All CompetitorsInsiders & InstitutionsProShare Advisors LLCSold 1,283 shares on 5/26/2023Ownership: 0.019%Capital Impact Advisors LLCBought 1,699 shares on 5/23/2023Ownership: 0.045%Putnam Investments LLCBought 31,408 shares on 5/22/2023Ownership: 0.191%Ameriprise Financial Inc.Bought 19,090 shares on 5/22/2023Ownership: 0.174%New York State Common Retirement FundBought 45,119 shares on 5/18/2023Ownership: 0.152%View All Insider TransactionsView All Institutional Transactions TWST Stock - Frequently Asked Questions Should I buy or sell Twist Bioscience stock right now? 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Twist Bioscience in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" TWST shares. View TWST analyst ratings or view top-rated stocks. What is Twist Bioscience's stock price forecast for 2023? 6 Wall Street analysts have issued 1-year price objectives for Twist Bioscience's stock. Their TWST share price forecasts range from $18.00 to $36.00. On average, they anticipate the company's share price to reach $26.17 in the next twelve months. This suggests a possible upside of 57.0% from the stock's current price. View analysts price targets for TWST or view top-rated stocks among Wall Street analysts. How have TWST shares performed in 2023? Twist Bioscience's stock was trading at $23.81 on January 1st, 2023. Since then, TWST shares have decreased by 30.0% and is now trading at $16.67. View the best growth stocks for 2023 here. When is Twist Bioscience's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, August 4th 2023. View our TWST earnings forecast. How were Twist Bioscience's earnings last quarter? Twist Bioscience Co. (NASDAQ:TWST) released its quarterly earnings data on Friday, May, 5th. The company reported ($1.06) EPS for the quarter, beating analysts' consensus estimates of ($1.09) by $0.03. The business had revenue of $60.18 million for the quarter, compared to analyst estimates of $56.61 million. Twist Bioscience had a negative net margin of 93.32% and a negative trailing twelve-month return on equity of 27.95%. What ETFs hold Twist Bioscience's stock? ETFs with the largest weight of Twist Bioscience (NASDAQ:TWST) stock in their portfolio include ARK Genomic Revolution ETF (ARKG), iShares Genomics Immunology and Healthcare ETF (IDNA), Global X Telemedicine & Digital Health ETF (EDOC), ROBO Global Healthcare Technology and Innovation ETF (HTEC), SPDR S&P Biotech ETF (XBI), ARK Innovation ETF (ARKK), Direxion Daily S&P Biotech Bull 3x Shares (LABU) and Hypatia Women CEO ETF (WCEO). What guidance has Twist Bioscience issued on next quarter's earnings? Twist Bioscience updated its FY 2023 earnings guidance on Sunday, May, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $235.00 million-$238.00 million, compared to the consensus revenue estimate of $264.18 million. What is Emily Leproust's approval rating as Twist Bioscience's CEO? 44 employees have rated Twist Bioscience Chief Executive Officer Emily Leproust on Glassdoor.com. Emily Leproust has an approval rating of 83% among the company's employees. What other stocks do shareholders of Twist Bioscience own? Based on aggregate information from My MarketBeat watchlists, some companies that other Twist Bioscience investors own include CrowdStrike (CRWD), Pfizer (PFE), DocuSign (DOCU), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Gilead Sciences (GILD), JD.com (JD), Tesla (TSLA) and Twilio (TWLO). When did Twist Bioscience IPO? (TWST) raised $75 million in an initial public offering on Wednesday, October 31st 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Cowen served as the underwriters for the IPO and Allen & Company and Baird were co-managers. What is Twist Bioscience's stock symbol? Twist Bioscience trades on the NASDAQ under the ticker symbol "TWST." Who are Twist Bioscience's major shareholders? Twist Bioscience's stock is owned by a variety of institutional and retail investors. Top institutional investors include ARK Investment Management LLC (12.63%), BlackRock Inc. (10.93%), State Street Corp (9.23%), JPMorgan Chase & Co. (7.10%), Sumitomo Mitsui Trust Holdings Inc. (5.98%) and Nikko Asset Management Americas Inc. (5.98%). Insiders that own company stock include Dennis Cho, Emily M Leproust, Emily M Leproust, James M Thorburn, Jan Johannessen, John P Molloy, Keith Crandell, Mark Daniels, Nicolas Barthelemy, Patrick John Finn, Patrick Weiss, Paula Green, Robert Chess and William Banyai. View institutional ownership trends. How do I buy shares of Twist Bioscience? Shares of TWST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Twist Bioscience's stock price today? One share of TWST stock can currently be purchased for approximately $16.67. How much money does Twist Bioscience make? Twist Bioscience (NASDAQ:TWST) has a market capitalization of $952.69 million and generates $203.57 million in revenue each year. The company earns $-217,860,000.00 in net income (profit) each year or ($3.77) on an earnings per share basis. How many employees does Twist Bioscience have? The company employs 652 workers across the globe. How can I contact Twist Bioscience? Twist Bioscience's mailing address is 681 GATEWAY BLVD., SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.twistbioscience.com. The company can be reached via phone at (800) 719-0671 or via email at maeve@argotpartners.com. This page (NASDAQ:TWST) was last updated on 6/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.